Share Name Share Symbol Market Type Share ISIN Share Description
Heiq Plc LSE:HEIQ London Ordinary Share GB00BN2CJ299 ORD GBP0.30
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 35.00 0.00 00:00:00
Bid Price Offer Price High Price Low Price Open Price
34.50 36.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 36.86 5.14 3.08 10.3 44
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 35.00 GBX

Heiq (HEIQ) Latest News

More Heiq News
Heiq Investors    Heiq Takeover Rumours

Heiq (HEIQ) Discussions and Chat

Heiq Forums and Chat

Date Time Title Posts
19/1/202312:07Heiq with all information72
06/6/202220:11Super Textile With Impressive Potential595

Add a New Thread

Heiq (HEIQ) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2023-01-26 16:35:2635.001,400490.00UT
2023-01-26 14:54:2235.401,388491.35O
2023-01-26 14:48:2535.0010,0003,500.00O
2023-01-26 14:34:1135.401,412499.85O
2023-01-26 13:20:5235.5030,00010,650.00O
View all Heiq trades in real-time

Heiq (HEIQ) Top Chat Posts

Top Posts
Posted at 26/1/2023 08:20 by Heiq Daily Update
Heiq Plc is listed in the Chemicals sector of the London Stock Exchange with ticker HEIQ. The last closing price for Heiq was 35p.
Heiq Plc has a 4 week average price of 23.50p and a 12 week average price of 23.50p.
The 1 year high share price is 108.75p while the 1 year low share price is currently 23.50p.
There are currently 125,891,904 shares in issue and the average daily traded volume is 99,758 shares. The market capitalisation of Heiq Plc is £44,062,166.40.
Posted at 19/1/2023 12:07 by bad gateway
They still have lycra. They congratulated them on the Hugo push via linkedin whilst gently reminding them both that "they're" the global partner.

The LYCRA Company


Congratulations to HeiQ AeoniQ™ & HUGO BOSS on the first of many garments made with this revolutionary fiber! As the exclusive global distributor for HeiQ AeoniQ fiber, we look forward to the ongoing impact this sustainable solution will have on the apparel industry.

Posted at 06/1/2023 08:29 by baner
You do not ”pump up the share price” with some small purchases…R30;…..he most likely see some good value in the stock at this price. As simple as that.
Posted at 06/1/2023 07:39 by pugugly
Or is he just trying to pump up the share price prior to a new placing?
Posted at 05/1/2023 07:21 by babbler
HeiQ Plc (LSE: HEIQ), a leading company in materials innovation and hygiene technologies, has been notified that on 4 January 2023, Carlo Centonze, Chief Executive Officer of the Company, purchased 300,000 ordinary shares in the Company ("Ordinary Shares") at an average price of 28 pence per share.
Posted at 04/1/2023 08:29 by 74tom
“74tom14 Apr '22 - 06:47 - 568 of 595 Edit
0 2 0
Beat revised top line revenue but gross margins missed by 3%. Operating profit of $3.4m missed the Cenkos forecast of $3.84m by ~10% & operating margin came in at 5.9%, well below the 7.7% forecast (and back in line with what they achieved in 2018 & 2019). H2 operating margins very poor indeed (H1 was 12.8%).

Still looks expensive at £100m market cap given the margin erosion, it looks to me as thought they’re chasing top line growth as a vanity metric which IMO isn’t going to help the share price”
This opinion has been completely vindicated by todays horrendous update, which borders on the disgraceful.

If you’re going to miss top line revenues by ~20% then there is no way you should be allowed to wait until after year end to notify the market, particularly if you’re going to use China as an excuse.

With the outlook statement, unknown cash balance & apparent addiction to acquisitions I still don’t think it’s a buy at £35m cap. Wait for the full year results and hugely dilutive placing IMO.

Posted at 03/12/2022 15:49 by slim9
£90 Million Game Changer Here..........

As previously announced on 19 March 2021, ICP signed an Exclusive Licence and Chemicals Supply Agreement ("the Exclusive Agreement") to apply HeiQ Viroblock for printing processes such as commercial print, food, beverage and pharma packaging, in return for royalty payments to HeiQ. ICP has breached the Exclusive Agreement by failing to pay royalties or minimum exclusivity fee payments and failing to provide timely and accurate royalty reports. Contractual minimum exclusivity fees for the contract term amount to USD $30 million in total.

HeiQ seeks an order that would require the defendant to comply with its long-standing contractual obligations to HeiQ and given the exclusive terms is asking for treble damages under North Carolina law.

Posted at 26/10/2021 08:35 by bad gateway
Missed the press conference. Decent piece on the website though and sounds quite a product for our new net zero world.

October 26, 2021
HeiQ announces a potential game-changer for the textile industry with the introduction of HeiQ AeoniQ – a high performance cellulose yarn based on a new fiber derived from carbon negative materials. This new fiber, which is derived from third generation cellulosic biopolymers, is advancing to pilot production prior to mass commercialization. The LYCRA Company is first to join HeiQ as a development partner.

Whether it is cotton, wool or synthetic polymers, global textile production has a significant environmental impact with the industry responsible for more than 10% of global greenhouse gas emissions and over 20% of wastewater worldwide1. Conventional cellulosic fiber production uses arable land during growth and has limited design versatility, while raw materials for fossil-based synthetic materials are finite. Existing methods to recycle textile fabrics and garments made with all fibers are, for the most part, still not at scale and most fibers – whether synthetic or natural – take many years to degrade in landfills or oceans, leading to environmental build up.

HeiQ AeoniQ cellulosic yarn made of climate positive raw materials

HeiQ AeoniQ yarns (Aeon: striving for eternal circularity) are made out of cellulosic biopolymers that during growth bind carbon from the atmosphere while generating oxygen. This high-performance yarn is positioned to potentially substitute synthetic filament yarns which constitute over 60% of global annual textile output of 108 million metric tons 2. Further, when compared to conventional cellulosic products, HeiQ AeoniQ yarns do not draw on arable land, pesticides or fertilizer in their production.

HeiQ AeoniQ yarns are designed for cradle-to-cradle circularity and can be recycled repeatedly while maintaining consistent fiber quality. The manufacturing process is expected to consume 99% less water than cotton yarns and HeiQ AeoniQ is designed to offer comparable performance properties to polyester, nylon and conventional regenerated cellulose yarns.

Inviting first adopters

HeiQ’s leading industry experts stand ready to deliver the first HeiQ AeoniQ yarns from the pilot production plant in Q2 2022. Given the outstanding qualities, the unique decarbonizing potential offered and outstanding ESG3 credentials, HeiQ is inviting a maximum of 20 sustainability-driven brand partners to be the first to market with products made of this game-changing future yarn.

The LYCRA Company as a primary development partner

HeiQ announces that The LYCRA Company, with its renowned collection of brands, global retail customer network and fabric innovation capabilities, will be a primary apparel development partner for HeiQ AeoniQ yarns with an exclusivity for stretch and performance fabrics. The LYCRA Company has a complete range of certified, sustainable products and is continuously complementing this range via the development of new types of LYCRA® fiber. These fibers have the potential to be combined with HeiQ AeoniQ yarn to create unique decarbonizing and degradable elastic fabrics.

HeiQ Group Co-founder and CEO, Carlo Centonze states:“Climate change needs new inventions. By bringing HeiQ AeoniQ yarn to the textile industry, we will reduce our dependence on oil-based fibers, help decarbonize our planet and reduce the impact of the industry on climate change. Our yarn is a versatile alternative to polyester, nylon, and even conventional cellulosics and therefore has huge industry transformation potential. By wearing clothes made of HeiQ AeoniQ consumers can act in support of reducing C02 in our atmosphere. Adoption by billions of people offers potential to bind hundreds of millions of tons of CO2 from the atmosphere. A battle worth the fight.”

The LYCRA Company CEO Julien Born notes: “With our future company strategy centering on sustainable solutions for the textile industry, we are proud to partner with HeiQ in both the technical development and commercialization of this fiber. The industry is ready for innovations such as HeiQ AeoniQ, and by combining our capabilities with those of HeiQ, we are truly well positioned to learn quickly and maximize the huge potential of this new technology.”

Mr. Martin Gebert-Germ, a viscose filament yarn expert with 30 years of experience in the textile industry, stated, “This technology is the game changer for the whole textile industry.” Mr. Gebert-Germ, will join the newly-established HeiQ GmbH Austria as CEO and will be leading the HeiQ AeoniQ business from November 2021.

The World Bank 2019
Environment, Social, Governance

Posted at 22/9/2021 15:14 by cottoner
September 22, 2021

WILMINGTON, Del.—September 22, 2021— Textile technology innovation leaders, HeiQ and The LYCRA Company, today announced they will be introducing LYCRA® freshFX® brand with HeiQ technology for the China market.

“LYCRA® freshFX® brand with HeiQ technology is the first product resulting from a collaboration between The LYCRA Company and HeiQ that we announced in July,” said Steve Stewart, chief brand and innovation officer, The LYCRA Company. “The goal of this partnership is to combine our strengths to bring more market- relevant, innovative and sustainable textile technologies to consumers more quickly.”

Garments made with LYCRA® freshFX® brand with HeiQ technology will offer consumers the renowned LYCRA® fiber benefits of lasting comfort, fit and shape, combined with HeiQ’s freshness and hygiene textile technologies. From odor absorption, antimicrobial to antiviral, with bio-based, mineral-based and silver-based technologies, HeiQ provides a comprehensive product range, now available with fabrics made with LYCRA® fiber.

LYCRA® freshFX® brand with HeiQ technology can be used in activewear, athleisure apparel, personal protective equipment, socks, underwear, wovens, and non-apparel uses. The HeiQ finishes are applied directly to stretch fabrics made with LYCRA® fiber branded spandex. LYCRA® freshFX® brand with HeiQ technology can be customized to exact consumer needs via antiviral, antimicrobial, or anti-odor technology options.

Fabrics featuring this technology are tested to ensure they meet the relevant national Guobiao (GB) standards for China as well as the established quality standards of both The LYCRA Company and HeiQ. Once certified, garments are eligible for identification at retail via physical or virtual hangtags.

The all-day benefits of LYCRA® freshFX® brand with HeiQ technology will help consumers feel more comfortable and confident even after extended use. Garments with these freshness and hygiene innovations also have the potential to be laundered less, which would reduce water and energy consumption.

“It has been exciting to team up with The LYCRA Company to bring our combined technologies to the China market first,” said Carlo Centonze, Co-founder and CEO of HeiQ Group. “The new generation of Chinese consumers are much more tech-savvy and looking for more comfort and functionality in their everyday clothes. LYCRA® freshFX® brand with HeiQ technology will deliver the functional benefits consumers desire today throughout a wide range of garment categories. I am really looking forward, together with The LYCRA Company, to bring new products to satisfy these growing consumer needs.”

Both HeiQ and The LYCRA Company will be exhibiting at the upcoming Intertextile Shanghai. For product information and fabric samples, visit HeiQ (Booth C78) and The LYCRA Company (Booth E51) in Hall 1.1 at Intertextile Shanghai, October 9-11. For show information, visit


Posted at 20/9/2021 09:04 by cottoner
September 20, 2021

HeiQ XReflex technology for enhanced insulation with less bulk will make its first to market appearance in gloves from Outdoor Research.

Zürich, Switzerland, 20 September 2021 – Outdoor Research, the Seattle-based leader in performance apparel and outdoor gear, launches its RadiantX Gloves and Mitts this fall, a new line of insulated handwear, making it the first brand to use revolutionary HeiQ XReflex Radiant Barrier Technology on gloves.

The patented HeiQ XReflex Radiant Barrier technology was the finish of choice for the gloves and mitts as, unlike standard insulation systems, it provides enhanced warmth with less bulk and weight by reflecting radiant body heat to keep warmth in. The revolutionary technology utilizes ultra-thin surface coatings to reflect radiant body heat, improving thermal retention without reducing breathability. A perfect application of the technology is on gloves, where dexterity is crucial but can’t come at the expense of warmth.

Pioneering New Technologies – Outdoor Research at the Forefront of Innovation

Scheduled for launch in the USA, Canada and Internationally in Fall 2021, RadiantX Gloves and Mitts provide enhanced warmth when a slim profile is paramount to safety and agility. That means retaining function while handling cold objects like ice axes, pickets, and carabiners, and keeping fingers nimble and active with rope work, knots, rappelling and belaying.

Four decades into glove and mitt manufacturing, Outdoor Research continues to strive for advancements in new technologies that change the way outdoor enthusiasts approach extreme environments. As the first company with HeiQ XReflex enhanced gloves, Outdoor Research found the perfect technology to address an age-old challenge: How to retain warmth in palms and fingers without sacrificing dexterity.

“It was a no-brainer to partner with HeiQ on the HeiQ XReflex technology as it pairs both lightweight warmth and breathability — two qualities that you would want on any active cold weather glove” said Jenny Dashner, Outdoor Research Product Manager for Gloves. “The beauty of using it in the RadiantX glove is that we could place a thin, yet warm insulation in it without compromising the dexterity of the glove and mitt. Many ski and alpine athletes have told us that this is now their new favorite.”

Carlo Centonze, Co-founder & CEO of HeiQ, said: “HeiQ XReflex is truly a revolutionary technology, especially for those who spend a lot of time in the outdoors, sometimes facing extreme weather conditions and cold. We couldn’t have found a better partner than Outdoor Research as the first company to implement this exceptional insulation for their high-performance gloves. Outdoor Research shares many philosophies with HeiQ so it’s not a surprise that many of their products are enhanced with HeiQ technologies. I wish all their mountaineering customers much success as they climb to new heights with warm and comfortable hands.”

HeiQ XReflex Radiant Barrier Technology

HeiQ XReflex, created by HeiQ’s joint-venture partner Xefco, is a patented radiant barrier technology that makes products thinner, lighter and warmer. HeiQ XReflex ultilizes an ultra-thin reflective surface coating that reflects energetic infrared body heat waves back to the body. The radiant barrier coating is applied to one side of the fabric via a high-tech vapor deposition process that doesn’t compromise the fabric’s air permeability, noise, touch, durable water repellence (DWR) or down proof properties. The radiant barrier textiles are combined together with optimized insulation materials to produce insulated assemblies with up to 50% less volume and weight while keeping the same level of warmth (measured in CLO). HeiQ XReflex is available on fabrics and non-woven scrims and lasts over 20 washes.

Tom Hussey, CEO and Co-Founder, Xefco says: “We are so proud to see our technology used by Outdoor Research, their innovative mountaineering gloves are an ideal product for our ground-breaking radiant barrier technology. We wish their users a safe and satisfactory ascent.”


Posted at 03/3/2021 07:10 by jammytass
3 March 2021

HeiQ Plc

Acquisition of 51% of Industrial Biotech Business, Chrisal

HeiQ Plc (LSE:HEIQ), an established global brand in materials and textile innovation which operates in high-growth markets, is pleased to announce that it has signed an agreement to acquire 51% of the share capital and voting rights of Chrisal N.V., Belgium ("Chrisal", "the Acquisition"). The Acquisition is for a consideration of €7.5 million, with €5.0 million payable in cash and €2.5 million through the issue of 1,101,928 new ordinary shares by HeiQ. On completion, Chrisal will be renamed HeiQ Chrisal.

Chrisal is a profitable industrial biotechnology company and a leader in innovative ingredients and consumer products that incorporate the benefits of probiotics and synbiotics. It has 120 products within its three technology platforms that create healthy and sustainable microbial ecosystems. The application of its proprietary technology includes cosmetics, personal care, textiles, wound dressings, water purification, air treatment and cleaning products. Chrisal has recently developed a synbiotic interior cleaner, Synbio®, for healthcare and hospitals, a project sponsored by The Gates Foundation. Early results have indicated Synbio® cleaners to be equal to disinfectants and detergents but without bacterial resistance downsides, while offering enhanced cleaning performance.

The Acquisition is aligned with HeiQ's strategy of becoming a global leader in materials innovation. It also solidifies HeiQ's position as a profitable and fast-growing pioneer in the $24 billion global textile chemicals market. HeiQ already directly serves the $10 billion antimicrobial textile market with its HeiQ Viroblock and HeiQ Pure technology platforms and the Acquisition will strengthen its presence with a complementary probiotic platform while enabling it to enter the new adjacent and lucrative markets of surface hygiene treatment, water purification and probiotic personal care.

Additional Highlights
· Chrisal recorded revenue of €5.5 million for the 12 months to 31 December 2020, an increase of 62% compared to 2019, and an operating profit of €1.6 million (28.9%) - unaudited.

· Chrisal has over 500 commercial customers in 25 countries, including hospitals, food and cosmetic manufacturers, presenting HeiQ with compelling cross-selling opportunities for its existing core product range. Chrisal will benefit from HeiQ's extensive customer and distribution network, as well as its marketing prowess.

· Chrisal customers include Q viva, Ahava, Atena-Alfa, Probilife, Sonax, Woellner and Greenspeed

· The Acquisition includes a bottling facility in Belgium. This is an important infrastructure requirement for HeiQ's ambitions in functional textile aftercare and other fields.

· The current Chrisal President and Founder Corrie Gielen and its CEO/CTO Dr. Robin Temmerman will continue to lead the business, supported by the existing Chrisal team.

· HeiQ co-Founder and Group CEO Carlo Centonze as well as Group CFO Xaver Hangartner will join the HeiQ Chrisal Board of Directors and will explore further synergies over the course of 2021.

· HeiQ Chrisal will be responsible for the creation, production and commercialisation of its products, with HeiQ acting as its corporate service hub and extended commercialization arm.

· Chrisal's patented technology carries the prestigious EU Ecolabel, a label of excellence that is awarded solely to products meeting high environmental standards throughout their lifecycle.

HeiQ co-founder and CEO Carlo Centonze said:

"The acquisition of a majority stake in Chrisal brings multiple benefits to HeiQ and its shareholders. HeiQ Chrisal will provide us with revenue from other fast-growth markets adjacent to those we serve already, as well as exciting cross-selling opportunities for our and their existing core product range. The acquisition will progress our direct to consumer offer and enlarges our product offering to hygiene-sensitive environments, such as the healthcare sector.

"Chrisal's technology platform includes an anti-allergen effect for mattresses and bedding, microbial and viral protection for surfaces, anti-inflammatory effects in wound dressings, probiotic skin enhancing cosmetics, algae and biofilm control in drinking water as well as advanced synbiotic protection to replace the resistance-creating antibiotics in animal husbandry. We are particularly excited about Chrisal's synbiotic technology solution for healthcare and hospitals for which full clinical results are due to be published imminently in a leading journal.

"HeiQ is increasingly becoming more than a textile technology company; we are innovating materials more broadly. This acquisition of a leading probiotics business is aimed at making HeiQ a leader in probiotic innovation, positioning us well to serve many lucrative segments of this fast growth USD 50 billion market.

"Chrisal's culture of entrepreneurship, people empowerment, sustainability, innovation and lean processes are a perfect match with HeiQ. I expect this partnership to become a great success and we will look forward to working closely with Corrie, Robin and the rest of the Chrisal team."

Corrie Gielen, President of Chrisal commented:
"For 30 years Chrisal has built on new technologies to improve our world in a sustainable way. With our latest patented Synbio® technology we have found the best solution to strengthen products, people and our environment. We are confident that the new partnership with HeiQ will bring us the additional competences and network needed to globalize this beautiful and groundbreaking technology. Together we combine the best of nature with the latest in science to make the difference for a better world."

Further Information on Chrisal:

Chrisal is an industrial biotechnology leader in prebiotic, probiotic and synbiotic technologies and products. With its 120 products, Chrisal serves commercial and consumer customers operating in the markets of cosmetics, personal care, textiles, wound dressings, water and air purification and cleaning solutions for hospitals and animal husbandry. Early results from clinical trials for Chrisal's patented Synbio®, an active synbiotic surface cleaner, suggest that it could be the next generation technology to probiotic surface cleaners, such as Reckitt Benckiser's VEO. Chrisal technology carries the prestigious EU Ecolabel, a label of environmental excellence that is awarded solely to products meeting high environmental standards throughout their lifecycle.

The industrial biotech acquisition will provide HeiQ access to the technology platform of prebiotics, probiotics and postbiotics for bio-based odor & stain control for carpet & footwear, anti-allergen effect in mattress and bedding, microbial and viral protection for surfaces, anti-inflammatory effect in wound dressings, probiotic skin enhancing cosmetics, algae and biofilm control in drinking water as well as advanced synbiotic protection replacing the resistance-creating antibiotics in animal husbandry. With this strategic acquisition HeiQ enters the broader market of surface management and accesses a bio-based green complementary technology platform to its antimicrobials.

Chrisal's 120 products strengthen HeiQ's global product offering and will facilitate HeiQ's existing technology platforms into new markets.

Chrisal has a large, efficient manufacturing footprint in Lommel, Belgium and brings into the HeiQ group the strategic capability of bottling, a step required for HeiQ's B2C products ambitions in functional textile aftercare and other fields. Chrisal also includes a microbiology and molecular diagnostics lab for R&D and QC activities.

HeiQ Chrisal, the new corporate name for Chrisal, will continue to be led by President and Founder Corrie Gielen, its CEO/CTO Dr. Robin Temmerman as well as the entire Chrisal team. The entrepreneurial drive will be strengthened by HeiQ's Group support functions in Rapid & Deep R&D, Branding & Marketing, Regulatory and Compliance as well as Commercialisation. HeiQ co-Founder and Group CEO Carlo Centonze as well as Group CFO Xaver Hangartner will join the HeiQ Chrisal Board of Directors.

HeiQ Chrisal will be responsible for the creation, production and commercialization of its products, with the HeiQ Group acting as its corporate service hub and extended commercialization arm. Together, the newly enlarged Board will explore further synergies over the course of 2021.

Issue of Equity and Total Voting Rights

The Company will issue 1,101,928 new ordinary shares ("Consideration Shares") to the sellers of Chrisal, at a price of 1.9596p per share, which is the average 5 day closing price prior to signing, in order to part satisfy the consideration due. Applications will be made for the Consideration Shares to be admitted to the standard segment of the Official List, and to trading on the London Stock Exchange's Main Market ("Admission").

It is expected that Admission will become effective, and that dealings in the new Ordinary Shares are expected to commence, at 8.00 a.m. on 9 March 2021.

Following Admission, the total number of Ordinary Shares in issue will be 126'993'832 and the total number of voting rights will therefore be 126'993'832. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

This announcement contains inside information.

For further information, please contact:

HeiQ Plc

Heiq share price data is direct from the London Stock Exchange
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230127 07:30:22